BG105204A - Salts of paroxetine - Google Patents

Salts of paroxetine

Info

Publication number
BG105204A
BG105204A BG105204A BG10520401A BG105204A BG 105204 A BG105204 A BG 105204A BG 105204 A BG105204 A BG 105204A BG 10520401 A BG10520401 A BG 10520401A BG 105204 A BG105204 A BG 105204A
Authority
BG
Bulgaria
Prior art keywords
paroxetine
salts
peperidine
therapy
preparing
Prior art date
Application number
BG105204A
Other languages
Bulgarian (bg)
English (en)
Inventor
Victor JACEWICZ
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105204A publication Critical patent/BG105204A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
BG105204A 1998-07-02 2001-01-31 Salts of paroxetine BG105204A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (1)

Publication Number Publication Date
BG105204A true BG105204A (en) 2001-11-30

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105204A BG105204A (en) 1998-07-02 2001-01-31 Salts of paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (no)
JP (1) JP2002519421A (no)
KR (1) KR20010053337A (no)
CN (1) CN1314906A (no)
AP (1) AP2000002017A0 (no)
AU (2) AU4903999A (no)
BG (1) BG105204A (no)
BR (1) BR9911679A (no)
CA (1) CA2336470A1 (no)
CZ (1) CZ20004923A3 (no)
EA (1) EA200100098A1 (no)
GB (1) GB9814316D0 (no)
HU (1) HUP0103712A3 (no)
ID (1) ID27766A (no)
IL (1) IL140385A0 (no)
NO (1) NO20006547L (no)
PL (1) PL345365A1 (no)
SK (1) SK20242000A3 (no)
TR (1) TR200100055T2 (no)
WO (1) WO2000001692A1 (no)
ZA (2) ZA992899B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1622630T1 (sl) 2003-05-07 2012-12-31 Osteologix A/S Stroncijeva kombinacije za profilakso/zdravljenje patologij hrustanca in/ali kosti
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
KR101165614B1 (ko) 2004-02-26 2012-07-18 오스테올로지스 에이에스 괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
JP2010504281A (ja) * 2006-07-27 2010-02-12 エミスフェアー・テクノロジーズ・インク アリールスルファニル化合物、および活性薬剤を送達するための組成物
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用
CN116283778B (zh) * 2023-02-23 2025-08-29 江苏理工学院 一种吡唑羧酸类化合物及其制备方法和应用
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
EE03970B1 (et) * 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine

Also Published As

Publication number Publication date
GB9814316D0 (en) 1998-09-02
ZA992899B (en) 2000-03-29
JP2002519421A (ja) 2002-07-02
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (cs) 2001-08-15
HUP0103712A3 (en) 2002-09-30
SK20242000A3 (sk) 2001-07-10
IL140385A0 (en) 2002-02-10
PL345365A1 (en) 2001-12-17
AU2002100370A4 (en) 2002-06-06
NO20006547D0 (no) 2000-12-21
WO2000001692A1 (en) 2000-01-13
EP1091958A1 (en) 2001-04-18
NO20006547L (no) 2001-02-12
HUP0103712A2 (hu) 2002-05-29
AU4903999A (en) 2000-01-24
BR9911679A (pt) 2002-01-29
CN1314906A (zh) 2001-09-26
TR200100055T2 (tr) 2001-07-23
ZA200100020B (en) 2002-03-25
KR20010053337A (ko) 2001-06-25
CA2336470A1 (en) 2000-01-13
ID27766A (id) 2001-04-26
EA200100098A1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
ES2158778A1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
SE9704546D0 (sv) Novel compounds
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
MY125978A (en) Admantane derivatives
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
IL150201A0 (en) Novel piperidine and piperazine derivatives
BG64475B1 (bg) Ципразидонови соли
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
MY106315A (en) Pharmaceutical agents
MY127718A (en) Dolastatin 10 derivatives.
HRP20020330A2 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
SE9802937D0 (sv) Novel compounds
HUP0100336A3 (en) Vla-4 antagonists, pharmaceutical compositions comprising them and process for preparing them
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
AP2000002017A0 (en) Salts of paroxetine.
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
YU46302A (sh) Supstituisani piroli
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
DK1165596T3 (da) 14,15-alfa-methylen-equileninderivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse
HUP9801085A3 (en) Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient